Integra LifeSciences Holdings (IART)
Operating profit margin
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Operating income | US$ in thousands | 28,411 | 111,526 | 238,920 | 197,230 | 151,370 |
| Revenue | US$ in thousands | 1,608,880 | 1,486,360 | 1,506,670 | 1,533,950 | 1,298,690 |
| Operating profit margin | 1.77% | 7.50% | 15.86% | 12.86% | 11.66% |
December 31, 2024 calculation
Operating profit margin = Operating income ÷ Revenue
= $28,411K ÷ $1,608,880K
= 1.77%
Based on the provided data, Integra LifeSciences Holdings' operating profit margin has exhibited fluctuating trends over the last five years. The margin increased from 11.66% in December 2020 to 12.86% in December 2021, indicating a positive growth trajectory. This upward trend continued significantly in December 2022, reaching 15.86%, reflecting improved operational efficiency and profitability.
However, in December 2023, there was a noticeable decline in the operating profit margin to 7.50%, which may raise concerns about the company's ability to maintain profitability levels. This decrease could be attributed to various factors such as increasing costs or declining revenue.
The most recent data point, December 2024, shows a significant decline in the operating profit margin to 1.77%, marking a substantial decrease from the previous year. This sharp decline suggests that Integra LifeSciences Holdings experienced challenges in managing its operating expenses and generating profits efficiently.
In conclusion, the analysis of Integra LifeSciences Holdings' operating profit margin indicates a mixed performance over the past five years, with periods of growth followed by declines. The company may need to closely monitor its cost structures and revenue streams to sustain and improve its profitability in the future.
Peer comparison
Dec 31, 2024